Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation

BACKGROUND/OBJECTIVE: In a previous report of HIV-infected patients with fat redistribution, we found that recombinant human growth hormone (rhGH) therapy reduced visceral adipose tissue (VAT) but increased insulin resistance, and that the addition of rosiglitazone reversed the negative effects of r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:HIV Clin Trials
Main Authors: Leung, Vivien, Chiu, Ya-Lin, Kotler, Donald P., Albu, Jeanine, Zhu, Yuan-Shan, Ham, Kirsis, Engelson, Ellen S., Hammad, Hoda, Christos, Paul, Donovan, Daniel S., Ginsberg, Henry N., Glesby, Marshall J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941209/
https://ncbi.nlm.nih.gov/pubmed/27077672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15284336.2015.1126424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados